Introduction: MS-primarily based covalent binding assays specifically evaluate Kinact and Ki kinetics, enabling significant-throughput analysis of inhibitor potency and binding speed vital for covalent drug progress. every single drug discovery scientist knows the irritation of encountering ambiguous data when assessing inhibitor potency. When est